Literature DB >> 26241009

Discovery of nutritional biomarkers: future directions based on omics technologies.

Leticia Odriozola1, Fernado J Corrales.   

Abstract

Understanding the interactions between food and human biology is of utmost importance to facilitate the development of more efficient nutritional interventions that might improve our wellness status and future health outcomes by reducing risk factors for non-transmittable chronic diseases, such as cardiovascular diseases, cancer, obesity and metabolic syndrome. Dissection of the molecular mechanisms that mediate the physiological effects of diets and bioactive compounds is one of the main goals of current nutritional investigation and the food industry as might lead to the discovery of novel biomarkers. It is widely recognized that the availability of robust nutritional biomarkers represents a bottleneck that delays the innovation process of the food industry. In this regard, omics sciences have opened up new avenues of research and opportunities in nutrition. Advances in mass spectrometry, nuclear magnetic resonance, next generation sequencing and microarray technologies allow massive genome, gene expression, proteomic and metabolomic profiling, obtaining a global and in-depth analysis of physiological/pathological scenarios. For this reason, omics platforms are most suitable for the discovery and characterization of novel nutritional markers that will define the nutritional status of both individuals and populations in the near future, and to identify the nutritional bioactive compounds responsible for the health outcomes.

Entities:  

Keywords:  Diet; genomics; metabolomics; nutrition; proteomics; transcriptomics

Mesh:

Substances:

Year:  2015        PMID: 26241009     DOI: 10.3109/09637486.2015.1038224

Source DB:  PubMed          Journal:  Int J Food Sci Nutr        ISSN: 0963-7486            Impact factor:   3.833


  4 in total

Review 1.  Systems biology approaches to understand the effects of nutrition and promote health.

Authors:  Lina Badimon; Gemma Vilahur; Teresa Padro
Journal:  Br J Clin Pharmacol       Date:  2016-05-29       Impact factor: 4.335

2.  European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, Sweden, June 1 - 4, 2016: Abstracts.

Authors: 
Journal:  Obes Facts       Date:  2016-05-25       Impact factor: 3.942

3.  Metabolomics enables precision medicine: "A White Paper, Community Perspective".

Authors:  Richard D Beger; Warwick Dunn; Michael A Schmidt; Steven S Gross; Jennifer A Kirwan; Marta Cascante; Lorraine Brennan; David S Wishart; Matej Oresic; Thomas Hankemeier; David I Broadhurst; Andrew N Lane; Karsten Suhre; Gabi Kastenmüller; Susan J Sumner; Ines Thiele; Oliver Fiehn; Rima Kaddurah-Daouk
Journal:  Metabolomics       Date:  2016-09-02       Impact factor: 4.290

4.  Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss.

Authors:  Mona Adnan Aldubayan; Kristina Pigsborg; Sophia M O Gormsen; Francisca Serra; Mariona Palou; Pedro Mena; Mart Wetzels; Alberto Calleja; Antoni Caimari; Josep Del Bas; Biotza Gutierrez; Faidon Magkos; Mads Fiil Hjorth
Journal:  BMJ Open       Date:  2022-03-29       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.